New European Health Hotline
A new European hotline to increase public awareness of health care problems and to confront issues such as the safety of drugs and medical products has been launched from Belgium by the European Public Health Alliance.
The hotline, which has been welcomed by the European Commission, is being staffed by national experts from European Union member states. The questions it will answer will range from health care provision in various member states, health care reimbursement, validity of medical qualifications and cross-border health issues. It will also deal with drug safety, topical health issues and occupational medicine. A callback system has been installed to maximize accessibility.
The hotline number is +32 2 534 42 33, or fax +32 2 534 52 75. The hotline will also be available on the Internet.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze